Monday, January 3, 2011

Mouse experiments show: embryonic myoblasts slow heartbeat can be cured by

Russia national medical research personnel through the transplantation of embryonic Myoblast of successful cured mice analyses the heart diseases. Concerned experts pointed out that the research results will be similar to the treatment of human diseases. According to science and technology daily reported that the Russian researchers in selected patients in those analyses the disease mouse stroke. These mice in the number of heart beats per minute at 300-500 times, than the number of healthy mouse heart low 1 times; weight of 20 g to 25 g, normal mouse weight 30 grams in General to 40 g. Suffering from the disease in mice is easy in some experimental without harm (such as blood sampling) death. In the experiment, the researchers are suffering from this disease in mice with intravenous or intramuscular injection method of the transplantations 50 000 human embryos into muscle cells. Experiment 2 weeks later found that rats heartbeat of times not dependent on injection method to normalize. Experiments also found that seven months the heartbeat of normal mice, continues to be very good for those suffering from diseases of the heart beat of mice analyses the 3 months almost all killed, and that those who injected embryonic Myoblast, suffering from diseases of the heart beat of mice in most analyses the Live 8 months, some also fully again, like a normal mouse, like start a positive activity, bald spine also begin to grow hair. Currently, researchers are still not clear myoblasts mechanism of action of the heart, according to the documentary hypothesis that has been ported to the mouse in vivo embryo myoblasts no presence in the heart, but some also do not understand factors contributed to the heart itself stem cell development. Therefore, the researchers recommended that, in the use of cell transplantation in the treatment of muscular dystrophy disorders, consideration should be given to patients with cardiovascular status.

No comments:

Post a Comment